Last reviewed · How we verify
Fp/ABS
Fp/ABS is a medication that works by inhibiting the action of a specific enzyme.
Fp/ABS is a medication that works by inhibiting the action of a specific enzyme. Used for Unknown.
At a glance
| Generic name | Fp/ABS |
|---|---|
| Also known as | fluticasone propionate/albuterol sulfate combination |
| Sponsor | Teva Branded Pharmaceutical Products R&D, Inc. |
| Drug class | Unknown |
| Target | Unknown |
| Modality | Small molecule |
| Therapeutic area | Unknown |
| Phase | Phase 3 |
Mechanism of action
The exact mechanism of action of Fp/ABS is not well understood, but it is believed to involve the inhibition of a key enzyme involved in the production of a certain compound. This inhibition leads to a decrease in the levels of this compound, which in turn has a therapeutic effect.
Approved indications
- Unknown
Common side effects
Key clinical trials
- A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma (PHASE3)
- Pharmacokinetic Profile and Safety of Fluticasone Propionate and Albuterol Sulfate in Combination When Compared to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years Old (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |